Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors

Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect patient safety and ensure data integrity. This notice addresses the concerns of clinical trial sponsors and Canadians. 2021-05-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemicmanagement of clinical trialsnotice to clinical trial sponsorsestablished protocolpatient safetydata integrity Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsorsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsorsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/gestion-essai-clinique-pendant-pandemie-covid-19.html

During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect patient safety and ensure data integrity. This notice addresses the concerns of clinical trial sponsors and Canadians.

Data and Resources

Similar records